Press-release for stocks related to covid-19

Prices are updated after-hours

Ampio Pharmaceuticals' Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus Nephritis
Published: 2021-04-06 (Crawled : 13:35) - prnewswire.com
AMPE | $0.341 0.0% 830

| -80.79% | O: 2.26% H: 1.66% C: 0.0%
covid lupus covid-19

Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial
Published: 2021-04-06 (Crawled : 13:35) - biospace.com/
IQV | $238.62 3.15% 0.0% 1.1M

| 15.46% | O: -0.03% H: 1.74% C: 1.63%
MBRX | $4.45 3.49% 3.37% 7.4K

| 9.41% | O: 1.53% H: 0.0% C: -3.01%
covid potential trial covid-19

78%

22%

MTTR | News 4 | $4.6 164.37% 62.17% 28M

AGBA | $2.94 135.2% 57.48% 66M

EDBL | News | $6.46 71.81% 41.8% 2M

MTC | $2.25 44.23% 30.67% 6M

OPRT | News | $3.175 41.11% 29.13% 12M

SHIM | $3.05 35.56% 26.23% 1.1M

HKIT | $1.345 31.86% 24.16% 390K

ABVC | $1.36 30.77% 23.53% 7.4M

OST | $0.512 28.0% 21.88% 290K

POET | $1.59 27.2% 21.38% 4.2M

Save your searches and get alerts when important news are released.